Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.77
-0.0650-0.47%
Volume:10.15K
Turnover:139.27K
Market Cap:2.23B
PE:624.60
High:13.77
Open:13.72
Low:13.72
Close:13.83
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:1.58
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.25
PE(LYR):310.05

Loading ...

Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

TIPRANKS
·
Aug 11

Daiwa Securities Adjusts Price Target on Vertex Pharmaceuticals to $556 From $555, Maintains Buy Rating

MT Newswires Live
·
Aug 11

Vertex Pharmaceuticals added to ‘US 1 List’ at BofA

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals Inc. Stock Rises 5.6%, Outperforms Peers

Dow Jones
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals price target raised to $672 from $605 at BofA

TIPRANKS
·
Aug 11

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Early notable gainers among liquid option names on August 10th

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

TIPRANKS
·
Aug 06

Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays

TIPRANKS
·
Aug 05

Vertex Inc. Earnings Call Shows Profitable Growth

TIPRANKS
·
Aug 05

Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live
·
Aug 05

Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04